Image of a molecule.
Portrait of Zvi Kelman

Zvi Kelman

Research Biologist

Kelman Group

(240) 314-6294 zkelman@umd.edu

Dr. Zvi Kelman’s research is focused on developing tools and reagents for the labeling of biomolecules with stable isotopes to support biophysical and bioanalytical measurements. The NIST Biomolecular Labeling Laboratory (BL2) also provides support to external users through a proposal process. The laboratory has the equipment and reagents necessary for production, purification, and characterization of labeled proteins and other biomolecules, including peptides and nucleic acids. A part of these efforts includes the labeling of monoclonal antibodies (mAbs).  mAbs are commonly developed by the pharmaceutical industry as drugs to fight a large variety of diseases, including cancer and autoimmune disease. Some structural studies on mAbs will benefit from the ability to label the antibodies with stable isotopes. The lab is developing tools and reagents for bacteria, yeast, plant and mammalian cell expression and purification of labeled mAbs.

Another project pursued by the lab is the development of tools and reagents for next-generation protein sequencing.  Next-gen protein sequencing is an emerging technology that shows promise to revolutionize the field of proteomics, as next-generation DNA and RNA sequencing did for the fields of genomics and transcriptomics.